BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 31706886)

  • 1. The Lutonix AV Randomized Trial of Paclitaxel-Coated Balloons in Arteriovenous Fistula Stenosis: 2-Year Results and Subgroup Analysis.
    Trerotola SO; Saad TF; Roy-Chaudhury P;
    J Vasc Interv Radiol; 2020 Jan; 31(1):1-14.e5. PubMed ID: 31706886
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A randomized controlled trial of drug-coated balloon angioplasty in venous anastomotic stenosis of dialysis arteriovenous grafts.
    Liao MT; Lee CP; Lin TT; Jong CB; Chen TY; Lin L; Hsieh MY; Lin MS; Chie WC; Wu CC
    J Vasc Surg; 2020 Jun; 71(6):1994-2003. PubMed ID: 31611105
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Multicenter Global Registry of Paclitaxel Drug-Coated Balloon in Dysfunctional Arteriovenous Fistulae and Grafts: 6-Month Results.
    Karnabatidis D; Kitrou PM; Ponce P; Chong TT; Pietura R; Pegis JD; Ko PJ; Lin CH;
    J Vasc Interv Radiol; 2021 Mar; 32(3):360-368.e2. PubMed ID: 33495064
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Editor's Choice - Paclitaxel Coated Balloon Angioplasty vs. Plain Balloon Angioplasty for Haemodialysis Arteriovenous Access Stenosis: A Systematic Review and a Time to Event Meta-Analysis of Randomised Controlled Trials.
    Han A; Park T; Kim HJ; Min S; Ha J; Min SK
    Eur J Vasc Endovasc Surg; 2021 Oct; 62(4):597-609. PubMed ID: 34420890
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Randomized Controlled Trial for Paclitaxel-coated Balloon versus Plain Balloon Angioplasty in Dysfunctional Hemodialysis Vascular Access: 12-month Outcome from a Nonsponsored Trial.
    Pang SYC; Au-Yeung KCL; Liu GYL; Tse ROH; Lai D; Leung WKW; Mo KL; Tang CN; Yih PC
    Ann Vasc Surg; 2021 Apr; 72():299-306. PubMed ID: 33221299
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety and Efficacy of Paclitaxel-Eluting Balloon Angioplasty for Dysfunctional Hemodialysis Access: A randomized trial Comparing with Angioplasty Alone.
    Therasse E; Caty V; Gilbert P; Giroux MF; Perreault P; Bouchard L; Oliva VL; Lespérance J; Ethier J; Ouellet G; Francoeur M; Cournoyer S; Soulez G
    J Vasc Interv Radiol; 2021 Mar; 32(3):350-359.e2. PubMed ID: 33483226
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug Coated Balloons for Dysfunctional Haemodialysis Venous Access: A Patient Level Meta-Analysis of Randomised Controlled Trials.
    Fong KY; Zhao JJ; Tan E; Syn NL; Sultana R; Zhuang KD; Chua JME; Patel A; Irani FG; Tay KH; Tan BS; Too CW
    Eur J Vasc Endovasc Surg; 2021 Oct; 62(4):610-621. PubMed ID: 34362627
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A systematic review and meta-analysis of the risk of death and patency after application of paclitaxel-coated balloons in the hemodialysis access.
    Chen X; Liu Y; Wang J; Zhao J; Singh N; Zhang WW
    J Vasc Surg; 2020 Dec; 72(6):2186-2196.e3. PubMed ID: 32540324
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of juxta-anastomotic stenoses for failing distal radiocephalic arteriovenous fistulas: Drug-coated balloons versus angioplasty.
    Patanè D; Failla G; Coniglio G; Russo G; Morale W; Seminara G; Calcara G; Bisceglie P; Malfa P
    J Vasc Access; 2019 Mar; 20(2):209-216. PubMed ID: 30165791
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Paclitaxel-coated balloon fistuloplasty versus plain balloon fistuloplasty only to preserve the patency of arteriovenous fistulae used for haemodialysis (PAVE): study protocol for a randomised controlled trial.
    Karunanithy N; Mesa IR; Dorling A; Calder F; Katsanos K; Semik V; Robinson E; Peacock J; Das N; Forman C; Lawman S; Steiner K; Wilkins CJ; Robson MG
    Trials; 2016 May; 17(1):241. PubMed ID: 27175481
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of drug-coated balloon angioplasty versus conventional angioplasty for arteriovenous fistula stenosis: Systematic review and meta-analysis.
    Abdul Salim S; Tran H; Thongprayoon C; Fülöp T; Cheungpasitporn W
    J Vasc Access; 2020 May; 21(3):357-365. PubMed ID: 31595799
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and Safety of Paclitaxel-Coated Balloon Angioplasty for Dysfunctional Arteriovenous Fistulas: A Multicenter Randomized Controlled Trial.
    Yin Y; Shi Y; Cui T; Li H; Chen J; Zhang L; Yu Z; Li H; Yan Y; Wu K; Jin Q
    Am J Kidney Dis; 2021 Jul; 78(1):19-27.e1. PubMed ID: 33418016
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mortality After Paclitaxel-Coated Device Use in Dialysis Access: A Systematic Review and Meta-Analysis.
    Dinh K; Limmer AM; Paravastu SCV; Thomas SD; Bennett MH; Holden A; Varcoe RL
    J Endovasc Ther; 2019 Oct; 26(5):600-612. PubMed ID: 31455140
    [No Abstract]   [Full Text] [Related]  

  • 14. A systematic review and meta-analysis of drug-coated balloon versus conventional balloon angioplasty for dialysis access stenosis.
    Yan Wee IJ; Yap HY; Hsien Ts'ung LT; Lee Qingwei S; Tan CS; Tang TY; Chong TT
    J Vasc Surg; 2019 Sep; 70(3):970-979.e3. PubMed ID: 31445651
    [TBL] [Abstract][Full Text] [Related]  

  • 15. German Center Subanalysis of the LEVANT 2 Global Randomized Study of the Lutonix Drug-Coated Balloon in the Treatment of Femoropopliteal Occlusive Disease.
    Scheinert D; Schmidt A; Zeller T; Müller-Hülsbeck S; Sixt S; Schröder H; Weiss N; Ketelsen D; Ricke J; Steiner S; Rosenfield K
    J Endovasc Ther; 2016 Jun; 23(3):409-16. PubMed ID: 27117972
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Paclitaxel-coated balloon angioplasty vs. plain balloon dilation for the treatment of failing dialysis access: 6-month interim results from a prospective randomized controlled trial.
    Katsanos K; Karnabatidis D; Kitrou P; Spiliopoulos S; Christeas N; Siablis D
    J Endovasc Ther; 2012 Apr; 19(2):263-72. PubMed ID: 22545894
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment Effect of Drug-Coated Balloons Is Durable to 3 Years in the Femoropopliteal Arteries: Long-Term Results of the IN.PACT SFA Randomized Trial.
    Schneider PA; Laird JR; Tepe G; Brodmann M; Zeller T; Scheinert D; Metzger C; Micari A; Sachar R; Jaff MR; Wang H; Hasenbank MS; Krishnan P;
    Circ Cardiovasc Interv; 2018 Jan; 11(1):e005891. PubMed ID: 29326153
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative Effectiveness of Drug-Coated Balloon vs Balloon Angioplasty for the Treatment of Arteriovenous Fistula Stenosis: A Meta-analysis.
    Cao Z; Li J; Zhang T; Zhao K; Zhao J; Yang Y; Jiang C; Zhu R; Li Z; Wu W
    J Endovasc Ther; 2020 Apr; 27(2):266-275. PubMed ID: 32043432
    [No Abstract]   [Full Text] [Related]  

  • 19. Sustainable Antirestenosis Effect With a Low-Dose Drug-Coated Balloon: The ILLUMENATE European Randomized Clinical Trial 2-Year Results.
    Brodmann M; Werner M; Meyer DR; Reimer P; Krüger K; Granada JF; Jaff MR; Schroeder H;
    JACC Cardiovasc Interv; 2018 Dec; 11(23):2357-2364. PubMed ID: 30522663
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Percutaneous angioplasty using a paclitaxel-coated balloon improves target lesion restenosis on inflow lesions of autogenous radiocephalic fistulas: a pilot study.
    Lai CC; Fang HC; Tseng CJ; Liu CP; Mar GY
    J Vasc Interv Radiol; 2014 Apr; 25(4):535-41. PubMed ID: 24529550
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.